Overview

Zuojin Wan Combined With Rabeprazole or Mosapride for the Treatment of Functional Dyspepsia Combined With Depression

Status:
NOT_YET_RECRUITING
Trial end date:
2025-04-30
Target enrollment:
Participant gender:
Summary
To evaluate the symptom improvement of Zuojinwan combined with rabeprazole or Zuojinwan combined with a mosapride regimen in patients with functional dyspepsia combined with depression (liver-stomach depression-heat type) using rabeprazole or mosapride regimen as a control, and to compare the patients' adherence to the medication and the adverse effects between the two groups.
Phase:
NA
Details
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University
Treatments:
mosapride